Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031 (2019)
Attributed to:
Future-Proofing the Sustainability of the MRC High Throughput Sequencing Hub in Scotland
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-44089-3
PubMed Identifier: 31113993
Publication URI: http://europepmc.org/abstract/MED/31113993
Type: Journal Article/Review
Parent Publication: Scientific Reports
Issue: 1
ISSN: 2045-2322